Funding for this research was provided by:
Ministry of Health, Labour and Welfare (20K08777)
Received: 8 September 2021
Accepted: 23 November 2021
First Online: 11 December 2021
: Ethical approval for this study was provided by the Ethics Committee of Fukushima Medical University (No. 29282) and written informed consent was obtained from each individual.
: Not applicable.
: KM has received research Grants from Chugai, Pfizer, Eli Lilly and AbbVie. Rest of the authors declares that they have no competing interests.